Taiyo debuts CBD alternative

CPT can be legitimately distributed and consumed worldwide, has nerve-protecting properties and acts systemically on the central nervous system

Shutterstock 1163047840. Copyright: Cytis77

Taiyo used Vitafoods Europe, in Geneva, to debut its cannabidiol alternative, the most surprising innovation developed by Taiyo GmbH in Germany and partners for the European market. A legal cannabidiol (CBD) alternative that allows legal and safe consumption with a CBD effect.

The additive, CPT, which can be legitimately distributed and consumed worldwide, has nerve-protecting properties and acts systemically on the central nervous system.

Managing Director of the health-promoting natural ingredients expert, Dr Stefan Siebrecht, said: “CPT is by no means a synthetic cannabinoid, nor does it contain real cannabis. CPT is a combination of three natural and legal extracts which complement each other in such a way that they have a similar effect to CBD. The components of CPT are long established and are already being used in America to reduce the side effects of therapeutic cannabis. This makes the almost comparable effect all the more interesting.”

Siebrecht added: “CPT has an anti-inflammatory effect, relieves pain and reduces a number of stress-related symptoms. And although the ingredient improves sleep quality, it does not make you tired, but instead regulates the natural day-night rhythm. Improved concentration and learning ability are further positive effects.”

Companies